Global Veterinary Pain Management Market 2024-2028

Description

List of Tables

The veterinary pain management market is forecasted to grow by USD 800.12 mn during 2023-2028, accelerating at a CAGR of 6.99% during the forecast period. The report on the veterinary pain management market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising adoption of veterinary pain management due to increasing pet ownership, ongoing advancements in veterinary medicine market, and rise in adoption of veterinary pain management solutions for growing geriatric pet population.

Technavio's veterinary pain management market is segmented as below:

Market Scope
Base Year	2024
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	6.3%
CAGR	6.99%
Incremental Value	$800.12mn

By Product

Drugs
Devices

By Distribution Channel

Veterinary hospitals
Pet care clinics
Pharmacy stores

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increasing adoption of multimodal pain management approaches as one of the prime reasons driving the veterinary pain management market growth during the next few years. Also, growing trend of telemedicine in veterinary care facilitates and rising interest in nutraceuticals and alternative therapies will lead to sizable demand in the market.

The report on the veterinary pain management market covers the following areas:

Veterinary pain management market sizing
Veterinary pain management market forecast
Veterinary pain management market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading veterinary pain management market vendors that include Assisi Animal Health, Bimeda Holdings Ltd., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Chanelle Pharma Group, Dechra Pharmaceuticals Plc, Durvet Animal Health Products, Elanco Animal Health Inc., Manna Pro Products LLC, Multi Radiance Medical, Norbrook Laboratories Ltd., Vetoquinol SA, Virbac Group, and Zoetis Inc.. Also, the veterinary pain management market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR40044

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global veterinary pain management market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global veterinary pain management market 2018 - 2022 ($ million)
4.2 Product Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Product Segment 2018 - 2022 ($ million)
4.3 Distribution channel Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Distribution channel Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product

6.1 Market segments
Exhibit 30: Chart on Product - Market share 2023-2028 (%)
Exhibit 31: Data Table on Product - Market share 2023-2028 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 Drugs - Market size and forecast 2023-2028
Exhibit 34: Chart on Drugs - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Drugs - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Drugs - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Drugs - Year-over-year growth 2023-2028 (%)
6.4 Devices - Market size and forecast 2023-2028
Exhibit 38: Chart on Devices - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Devices - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Devices - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Devices - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Product
Exhibit 42: Market opportunity by Product ($ million)
Exhibit 43: Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by Distribution Channel

7.1 Market segments
Exhibit 44: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibit 45: Data Table on Distribution Channel - Market share 2023-2028 (%)
7.2 Comparison by Distribution Channel
Exhibit 46: Chart on Comparison by Distribution Channel
Exhibit 47: Data Table on Comparison by Distribution Channel
7.3 Veterinary hospitals - Market size and forecast 2023-2028
Exhibit 48: Chart on Veterinary hospitals - Market size and forecast 2023-2028 ($ million)
Exhibit 49: Data Table on Veterinary hospitals - Market size and forecast 2023-2028 ($ million)
Exhibit 50: Chart on Veterinary hospitals - Year-over-year growth 2023-2028 (%)
Exhibit 51: Data Table on Veterinary hospitals - Year-over-year growth 2023-2028 (%)
7.4 Pet care clinics - Market size and forecast 2023-2028
Exhibit 52: Chart on Pet care clinics - Market size and forecast 2023-2028 ($ million)
Exhibit 53: Data Table on Pet care clinics - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Chart on Pet care clinics - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Pet care clinics - Year-over-year growth 2023-2028 (%)
7.5 Pharmacy stores - Market size and forecast 2023-2028
Exhibit 56: Chart on Pharmacy stores - Market size and forecast 2023-2028 ($ million)
Exhibit 57: Data Table on Pharmacy stores - Market size and forecast 2023-2028 ($ million)
Exhibit 58: Chart on Pharmacy stores - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Pharmacy stores - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by Distribution Channel
Exhibit 60: Market opportunity by Distribution Channel ($ million)
Exhibit 61: Data Table on Market opportunity by Distribution Channel ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 China - Market size and forecast 2023-2028
Exhibit 91: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on China - Year-over-year growth 2023-2028 (%)
9.10 UK - Market size and forecast 2023-2028
Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.11 Japan - Market size and forecast 2023-2028
Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 103: Market opportunity By Geographical Landscape ($ million)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 Assisi Animal Health
Exhibit 111: Assisi Animal Health - Overview
Exhibit 112: Assisi Animal Health - Product / Service
Exhibit 113: Assisi Animal Health - Key offerings
12.4 Bimeda Holdings Ltd.
Exhibit 114: Bimeda Holdings Ltd. - Overview
Exhibit 115: Bimeda Holdings Ltd. - Product / Service
Exhibit 116: Bimeda Holdings Ltd. - Key offerings
12.5 Boehringer Ingelheim International GmbH
Exhibit 117: Boehringer Ingelheim International GmbH - Overview
Exhibit 118: Boehringer Ingelheim International GmbH - Business segments
Exhibit 119: Boehringer Ingelheim International GmbH - Key news
Exhibit 120: Boehringer Ingelheim International GmbH - Key offerings
Exhibit 121: Boehringer Ingelheim International GmbH - Segment focus
12.6 Ceva Sante Animale
Exhibit 122: Ceva Sante Animale - Overview
Exhibit 123: Ceva Sante Animale - Product / Service
Exhibit 124: Ceva Sante Animale - Key offerings
12.7 Chanelle Pharma Group
Exhibit 125: Chanelle Pharma Group - Overview
Exhibit 126: Chanelle Pharma Group - Product / Service
Exhibit 127: Chanelle Pharma Group - Key offerings
12.8 Dechra Pharmaceuticals Plc
Exhibit 128: Dechra Pharmaceuticals Plc - Overview
Exhibit 129: Dechra Pharmaceuticals Plc - Business segments
Exhibit 130: Dechra Pharmaceuticals Plc - Key offerings
Exhibit 131: Dechra Pharmaceuticals Plc - Segment focus
12.9 Durvet Animal Health Products
Exhibit 132: Durvet Animal Health Products - Overview
Exhibit 133: Durvet Animal Health Products - Product / Service
Exhibit 134: Durvet Animal Health Products - Key offerings
12.10 Elanco Animal Health Inc.
Exhibit 135: Elanco Animal Health Inc. - Overview
Exhibit 136: Elanco Animal Health Inc. - Product / Service
Exhibit 137: Elanco Animal Health Inc. - Key offerings
12.11 Manna Pro Products LLC
Exhibit 138: Manna Pro Products LLC - Overview
Exhibit 139: Manna Pro Products LLC - Product / Service
Exhibit 140: Manna Pro Products LLC - Key offerings
12.12 Multi Radiance Medical
Exhibit 141: Multi Radiance Medical - Overview
Exhibit 142: Multi Radiance Medical - Product / Service
Exhibit 143: Multi Radiance Medical - Key offerings
12.13 Norbrook Laboratories Ltd.
Exhibit 144: Norbrook Laboratories Ltd. - Overview
Exhibit 145: Norbrook Laboratories Ltd. - Product / Service
Exhibit 146: Norbrook Laboratories Ltd. - Key offerings
12.14 Vetoquinol SA
Exhibit 147: Vetoquinol SA - Overview
Exhibit 148: Vetoquinol SA - Business segments
Exhibit 149: Vetoquinol SA - Key news
Exhibit 150: Vetoquinol SA - Key offerings
Exhibit 151: Vetoquinol SA - Segment focus
12.15 Virbac Group
Exhibit 152: Virbac Group - Overview
Exhibit 153: Virbac Group - Business segments
Exhibit 154: Virbac Group - Key news
Exhibit 155: Virbac Group - Key offerings
Exhibit 156: Virbac Group - Segment focus
12.16 Zoetis Inc.
Exhibit 157: Zoetis Inc. - Overview
Exhibit 158: Zoetis Inc. - Business segments
Exhibit 159: Zoetis Inc. - Key news
Exhibit 160: Zoetis Inc. - Key offerings
Exhibit 161: Zoetis Inc. - Segment focus

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 162: Inclusions checklist
Exhibit 163: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 164: Currency conversion rates for US$
13.4 Research methodology
Exhibit 165: Research methodology
Exhibit 166: Validation techniques employed for market sizing
Exhibit 167: Information sources
13.5 List of abbreviations
Exhibit 168: List of abbreviations